Below is a guest post by Anthony J. Ryals, PhD, discussing a new study underway at Northwestern University looking at the effect chemotherapy and hormone depletion have on memory and cognition in cancer survivors.
By Anthony J. Ryals, PhD
Prior research has indicated that up to 90% of chemotherapy...
On Wednesday, May 29th, the California Assembly passed Bill AB 912. On July 10th, it will be addressed by the California Senate Health Committee. For those of you who are unfamiliar with California Bill AB 912, it is a bill that would require a health care service plan and a health insurer to...
There are nearly 7 million women survivors in the United States, 54.7% of all cancer survivors. These facts highlight the need to move survivorship education into the forefront of the conversation about cancer and thus, the Women Survivors Alliance (WSA) was born – created by women survivors, for...
Cancer survivors, their families and friends, and the Northwestern community that supports them , will come together on National Cancer Survivors Day, June 2nd, to walk and celebrate the 20th anniversary of the Robert H. Lurie Cancer Center's signature event, the Annual Cancer Survivors’...
Many of you may already know about the widely popular organization, Stupid Cancer, but for those of you who are new to our blog, Stupid Cancer is the nation's largest support community for young adult survivors of cancer. They support a global network of survivors, caregivers, providers and...
In April, the Oncofertility Consortium hosted a Virtual Grand Rounds with Clarisa Gracia, MD, MSCE, entitled, "Case Studies in Oncofertility," in which she discussed five theoretical young cancer patients and how oncofertility could be incorporated into their medical care. These patients included...
Since the 1990s, researchers have published conflicting results about the connection between cancer risk and fertility drugs. As a result, there has been a lingering concern among women that using fertility drugs may increase their risk for later developing hormone receptor positive cancers....
Wouldn’t it be great if insurance companies were required to provide coverage for medically necessary expenses for standard fertility preservation services when a medical treatment may directly or indirectly cause infertility to an enrollee or insured? California Assemblywoman Sharon Quirk-Silva,...
A new gentler chemotherapy drug in the form of nanoparticles has been designed by Northwestern Medicine® scientists to be less toxic to a young woman’s fertility but extra tough on cancer. This is the first cancer drug tested while in development for its effect on fertility using a...
There are an estimated 13 million cancer survivors living in the US today, with projected growth to 18 million by 2020. As a result, many healthcare groups and cancer centers are not equipped to address their growing survivor populations. Stemming from this need for quality after care, researchers...
By Danielle Alyce Fanslow, Francesca Duncan, and Kate Timmerman
There are several methods of fertility preservation open to female cancer patients who wish to start a family after treatment including cryopreservation of oocytes, embryos and ovarian tissue. Cryopreservation is a method of...
This is the final installment in a two-part blog story featuring Oncofertility Consortium member, Gregory Dolin, MD, JD, focusing on his recent Oncofertility Virtual Grand Rounds presentation. To read the 1st blog, click here.
In his presentation, Dr. Dolin highlighted some of...
Cancer during pregnancy is rare, occurring in approximately one out of every 1,000 pregnancies, with breast cancer being the most commonly diagnosed. In the past, both healthcare providers and women were often unclear about how to proceed with a pregnancy after a cancer diagnosis without...
Fertility preservation in young cancer patients has come a long way in the last decade, as both patients and the medical community have galvanized to improve the information and reproductive technologies available surrounding oncofertility. In response to the increased likelihood of young men and...
Several of our recent blog posts have discussed fertility preservation in females, so we’d like to take a little time to shine a light on some interesting oncofertility research focused on males. The Oncofertility Consortium is committed to exploring the reproductive future of all young cancer...
Below is a guest post by Oncofertility Consortium favorite and cancer survivor extraordinaire, Jenna Benn. Jenna is a young adult Gray Zone Lymphoma survivor, who preserved her fertility prior to beginning her cancer treatment in 2011. In the excerpt below, she writes about her experience as a...
The contents of the Oncofertility Consortium Blog are for informational purposes only and is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition.
965 Wilson Road, Room A626B
East Lansing, MI 48824-1316
Phone: 1 (517) 884 6434
Email: oncofert@msu.edu
NOTICE:
Ownership of this website has been transferred from Northwestern University to Michigan State University. Please note that some site information may be inaccurate while adjustments to reflect this organizational change are made.